RAPT Therapeutics, Inc. (RAPT)
NASDAQ: RAPT · IEX Real-Time Price · USD
2.790
-0.090 (-3.12%)
At close: Jul 2, 2024, 4:00 PM
2.860
+0.070 (2.51%)
After-hours: Jul 2, 2024, 4:39 PM EDT
RAPT Therapeutics Stock Forecast
RAPT's stock price has decreased by -85.29% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 6 analysts with 12-month price forecasts for RAPT Therapeutics stock have an average target of 18, with a low estimate of 4.00 and a high estimate of 40. The average target predicts an increase of 545.16% from the current stock price of 2.79.
Analyst Consensus: Hold
* Price targets were last updated on May 10, 2024.
Analyst Ratings
The average analyst rating for RAPT stock from 11 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 3 | 1 | 1 | 1 | 1 |
| Buy | 4 | 4 | 4 | 4 | 2 | 2 |
| Hold | 0 | 5 | 5 | 5 | 8 | 8 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 12 | 10 | 10 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wolfe Research | Wolfe Research | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | May 14, 2024 |
| Barclays | Barclays | Buy → Hold Downgrades $13 → $4 | Buy → Hold | Downgrades | $13 → $4 | +43.37% | May 10, 2024 |
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | May 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Apr 10, 2024 |
| JP Morgan | JP Morgan | Hold Maintains $15 → $13 | Hold | Maintains | $15 → $13 | +365.95% | Mar 27, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.69
from -3.05
EPS Next Year
-2.01
from -2.69
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | 51.8M | 212.6M | 327.2M |
| Avg | n/a | n/a | 25.1M | 88.2M | 155.6M |
| Low | n/a | n/a | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | 745.7% | 270.8% |
| Avg | - | - | - | 250.9% | 76.3% |
| Low | - | - | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.87 | -1.13 | -1.30 | -0.49 | 1.05 |
| Avg | -2.69 | -2.01 | -2.03 | -3.80 | -2.20 |
| Low | -3.24 | -3.61 | -2.78 | -6.85 | -5.20 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.